U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C17H20N2S
Molecular Weight 284.419
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ISOPROMETHAZINE

SMILES

CC(CN(C)C)N1C2=CC=CC=C2SC3=C1C=CC=C3

InChI

InChIKey=CGNHCKZJGQDWBG-UHFFFAOYSA-N
InChI=1S/C17H20N2S/c1-13(12-18(2)3)19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3

HIDE SMILES / InChI

Molecular Formula C17H20N2S
Molecular Weight 284.419
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

PubMed

PubMed

TitleDatePubMed
Hyperalgesia induced by Asp49 and Lys49 phospholipases A2 from Bothrops asper snake venom: pharmacological mediation and molecular determinants.
2003-05
The effects of acute doses of fexofenadine, promethazine, and placebo on cognitive and psychomotor function in healthy Japanese volunteers.
2003-04
Classic histamine H1 receptor antagonists: a critical review of their metabolic and pharmacokinetic fate from a bird's eye view.
2003-04
Histamine H1-receptor antagonists, promethazine and homochlorcyclizine, increase the steady-state plasma concentrations of haloperidol and reduced haloperidol.
2003-04
Clinical practice. Vestibular neuritis.
2003-03-13
Phenothiazine radicals inactivate Trypanosoma cruzi dihydrolipoamide dehydrogenase: enzyme protection by radical scavengers.
2003-03
Effect of some psychotropic drugs on luminol-dependent chemiluminescence induced by O2-, *OH, HOCl.
2003-02-04
Inactivation of cholinesterase induced by chlorpromazine cation radicals.
2003-02
Effect of phenothiazines on protein kinase C- and calcium-dependent activation of peritoneal macrophages.
2003-02
Interaction between various resistance modifiers and apoptosis inducer 12H-benzo[alpha]phenothiazine.
2003-01-18
Reye's syndrome: down but not out.
2003-01
Interaction of carbamazepine and promethazine in rabbits.
2003-01
In vitro human plasma leucine(5)-enkephalin degradation is inhibited by a select number of drugs with the phenothiazine molecule in their chemical structure.
2003-01
Antiemetic use in pediatric gastroenteritis: a national survey of emergency physicians, pediatricians, and pediatric emergency physicians.
2002-12-05
A systematic approach to the management of postoperative nausea and vomiting.
2002-12
Fibromyositis after intramuscular pentazocine abuse.
2002-11-15
TREC-Rio trial: a randomised controlled trial for rapid tranquillisation for agitated patients in emergency psychiatric rooms [ISRCTN44153243].
2002-10-16
Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase.
2002-10
Preparation, characterization and taste-masking properties of polyvinylacetal diethylaminoacetate microspheres containing trimebutine.
2002-10
Acute allergic reaction following contact with a spider.
2002-10
Enantioseparation of phenothiazines in cyclodextrin-modified micellar electrokinetic chromatography.
2002-09-20
Project USAP 2000--use of sedative agents by pediatric dentists: a 15-year follow-up survey.
2002-09-06
[Landau-Kleffner and autistic regression: the importance of differential diagnosis].
2002-09
A case of homicide by lethal injection with lidocaine.
2002-09
Recovery, enrichment and selectivity in liquid-phase microextraction comparison with conventional liquid-liquid extraction.
2002-07-19
Bradykinin is involved in hyperalgesia induced by Bothrops jararaca venom.
2002-07
Simultaneous determination of promethazine, chlorpromazine, and perphenazine by multivariate calibration methods and derivative spectrophotometry.
2002-06-27
Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay.
2002-06-19
In vitro reversal of chloroquine resistance in Plasmodium falciparum with dihydroethanoanthracene derivatives.
2002-06
Indirect spectrophotometric determination of propranolol hydrochloride and piroxicam in pure and pharmaceutical formulations.
2002-06
Central effects of cinnarizine: restricted use in aircrew.
2002-06
Next generation antihistamines: therapeutic rationale, accomplishments and advances.
2002-06
Investigation of interaction of promethazine with cyclodextrins.
2002-05-25
Interaction of protonated anticancer thiazines with water-insoluble phospholipids and antineoplastic agents.
2002-05-17
Liquid-phase microextraction of protein-bound drugs under non-equilibrium conditions.
2002-05
Anxiolytic premedication reduces preoperative anxiety and pain during oocyte retrieval. A randomized double-blinded placebo-controlled trial.
2002-05
Study of the stability of promethazine enantiomers by liquid chromatography using a vancomycin-bonded chiral stationary phase.
2002-04-25
Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets.
2002-04
Immunoassay screening of lysergic acid diethylamide (LSD) and its confirmation by HPLC and fluorescence detection following LSD ImmunElute extraction.
2002-04
[Validation of the HPLC method in the determination of dioxopromethazine and phenylephrine in eye drops].
2002-03
Inhibitory effects of H1-antihistamines on CYP2D6- and CYP2C9-mediated drug metabolic reactions in human liver microsomes.
2002-02
An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers.
2002-01
[A case of fluvoxamine overdose].
2002-01
[The activity of enzymes and free radical oxidation in acute and chronic fetal hypoxia in general anesthesia during cesarean section].
2002
Ketoconazole potentiates terfenadine-induced apoptosis in human Hep G2 cells through inhibition of cytochrome p450 3A4 activity.
2002
[Suicidal attempts with old (currently unused) drug].
2002
Antiallergic anti-inflammatory effects of H1-antihistamines in humans.
2002
Antihistamine antinociception is mediated by Gi-protein activation.
2002
[Work time distribution in night shift: are clinics facing a adjustment boom?].
2001-07
The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare.
2001
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:38:44 GMT 2025
Edited
by admin
on Mon Mar 31 18:38:44 GMT 2025
Record UNII
044033O3TY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FEN-BRIDAL
Preferred Name English
ISOPROMETHAZINE
MI   WHO-DD  
Common Name English
RP-4460
Code English
PROTHIAZIN
Brand Name English
PROMETHAZINE HYDROCHLORIDE IMPURITY B [EP IMPURITY]
Common Name English
N,N,.BETA.-TRIMETHYL-10H-PHENOTHIAZINE-10-ETHANAMINE
Systematic Name English
10-(2-DIMETHYLAMINOISOPROPYL)PHENOTHIAZINE
Common Name English
ISOPROMETHAZINE [MI]
Common Name English
ISOMETHAZINE
Common Name English
Isopromethazine [WHO-DD]
Common Name English
LILLY-01526
Code English
ISOPHENERGAN
Common Name English
Code System Code Type Description
FDA UNII
044033O3TY
Created by admin on Mon Mar 31 18:38:44 GMT 2025 , Edited by admin on Mon Mar 31 18:38:44 GMT 2025
PRIMARY
DRUG CENTRAL
3761
Created by admin on Mon Mar 31 18:38:44 GMT 2025 , Edited by admin on Mon Mar 31 18:38:44 GMT 2025
PRIMARY
WIKIPEDIA
ISOPROMETHAZINE
Created by admin on Mon Mar 31 18:38:44 GMT 2025 , Edited by admin on Mon Mar 31 18:38:44 GMT 2025
PRIMARY
EPA CompTox
DTXSID10952662
Created by admin on Mon Mar 31 18:38:44 GMT 2025 , Edited by admin on Mon Mar 31 18:38:44 GMT 2025
PRIMARY
PUBCHEM
110669
Created by admin on Mon Mar 31 18:38:44 GMT 2025 , Edited by admin on Mon Mar 31 18:38:44 GMT 2025
PRIMARY
SMS_ID
100000077371
Created by admin on Mon Mar 31 18:38:44 GMT 2025 , Edited by admin on Mon Mar 31 18:38:44 GMT 2025
PRIMARY
MERCK INDEX
m786
Created by admin on Mon Mar 31 18:38:44 GMT 2025 , Edited by admin on Mon Mar 31 18:38:44 GMT 2025
PRIMARY Merck Index
EVMPD
SUB14277MIG
Created by admin on Mon Mar 31 18:38:44 GMT 2025 , Edited by admin on Mon Mar 31 18:38:44 GMT 2025
PRIMARY
CAS
303-14-0
Created by admin on Mon Mar 31 18:38:44 GMT 2025 , Edited by admin on Mon Mar 31 18:38:44 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
Related Record Type Details
ACTIVE MOIETY